Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia

Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia

Abstract Acute Myeloid Leukemia (AML) in infants constitutes a rare and biologically distinct subgroup. Hematopoietic stem cell transplantation (HSCT) plays a pivotal role in the treatment of infant AML. However, the source of stem cells remains insufficiently explored. This study aimed to evaluate...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuyang Wang, Yibing Guo, Xiuxin Ling, Junhui Li, Tao Hu, Zhaoxia Zhang, Mengze Hu, Zeliang Song, Mei Yue, Ruihong Tang, Dixiao Zhong, Rong Liu
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Hematopoietic stem cell transplantation
Acute myeloid leukemia
Survival
Recurrence rates
Online Access:https://doi.org/10.1038/s41598-025-05602-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-05602-z

Similar Items